Approval · Notice of Compliance 15636 · 2014
MINT-HYDROXYCHLOROQUINE: Notice of Compliance 15636
Issued May 26, 2014
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 15636
- Date
- May 26, 2014
- Company
- Mint Pharmaceuticals IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Other
- Therapeutic class
- Anti-inflammatory; antimalarial
- Canadian reference product
- PLAQUENIL (Sanofi-Aventis Canada Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| MINT-HYDROXYCHLOROQUINE | 02424991 | Marketed |
Medicinal ingredients
- HYDROXYCHLOROQUINE SULFATE 200 MG per TAB